Evidence map›Paper›PMID 26685326›Full record

ArticleJournal of lipid research2016

SREBP-2-deficient and hypomorphic mice reveal roles for SREBP-2 in embryonic development and SREBP-1c expression.

Laurent Vergnes, Robert G Chin, Thomas de Aguiar Vallim, Loren G Fong, Timothy F Osborne, Stephen G Young, Karen Reue

Open access · hybridAbstract read
In one paragraph

Article in Journal of lipid research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 73 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Deciphering the Role of theInternational journal of molecular sciences · 2024
    Article
  9. Article
  10. Dominant missense variants in SREBF2 are associated with complex dermatological, neurological, and skeletal abnormalities.Genetics in medicine : official journal of the American College of Medical Genetics · 2024
    Article
  11. Review
  12. Article
  13. Biological functions of CRTC2 and its role in metabolism-related diseases.Journal of cell communication and signaling · 2023
    Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Laurent VergnesDepartments of Human Genetics David Geffen School of Medicine at the University of California, Los Angeles, CA 90095.
Robert G ChinDepartments of Human Genetics David Geffen School of Medicine at the University of California, Los Angeles, CA 90095.
Thomas de Aguiar VallimMedicine, David Geffen School of Medicine at the University of California, Los Angeles, CA 90095.
Loren G FongMedicine, David Geffen School of Medicine at the University of California, Los Angeles, CA 90095.
Timothy F OsborneMetabolic Disease Program, Sanford-Burnham Medical Research Institute, Orlando, FL 32827.
Stephen G YoungDepartments of Human Genetics David Geffen School of Medicine at the University of California, Los Angeles, CA 90095 Medicine, David Geffen School of Medicine at the University of California, Los Angeles, CA 90095 Molecular Biology Institute, University of California, Los Angeles, CA 90095.
Karen ReueDepartments of Human Genetics David Geffen School of Medicine at the University of California, Los Angeles, CA 90095 Medicine, David Geffen School of Medicine at the University of California, Los Angeles, CA 90095 Molecular Biology Institute, University of California, Los Angeles, CA 90095 reuek@ucla.edu.
University of California, Los Angeles · USSanford Burnham Prebys Medical Discovery Institute · US

Funding

Systems genomics of metabolic syndrome traitsP01HL028481 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI REUE, KAREN · 1985 to 2019
$50.2M
The Lipin Protein Family and Triglyceride Metabolism P01HL090553 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI YOUNG, STEPHEN G. · 2008 to 2018
$23.3M
THE NHLBI BAY AREA FUNCTIONAL GENOMICS CONSORTIUMU01HL066621 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI YOUNG, STEPHEN G · 2000 to 2007
$12.2M
NHLBI NIH HHS P01 HL028481NHLBI NIH HHS P01 HL090553NHLBI NIH HHS P01 HL90553NHLBI NIH HHS U01 HL066621NHLBI NIH HHS U01 HL66621
6 · The paper itself

Abstract

Cholesterol and fatty acid biosynthesis are regulated by the sterol regulatory element-binding proteins (SREBPs), encoded by Srebf1 and Srebf2. We generated mice that were either deficient or hypomorphic for SREBP-2. SREBP-2 deficiency generally caused death during embryonic development. Analyses of Srebf2(-/-) embryos revealed a requirement for SREBP-2 in limb development and expression of morphogenic genes. We encountered only one viable Srebf2(-/-) mouse, which displayed alopecia, attenuated growth, and reduced adipose tissue stores. Hypomorphic SREBP-2 mice (expressing low levels of SREBP-2) survived development, but the female mice exhibited reduced body weight and died between 8 and 12 weeks of age. Male hypomorphic mice were viable but had reduced cholesterol stores in the liver and lower expression of SREBP target genes. Reduced SREBP-2 expression affected SREBP-1 isoforms in a tissue-specific manner. In the liver, reduced SREBP-2 expression nearly abolished Srebf1c transcripts and reduced Srebf1a mRNA levels. In contrast, adipose tissue displayed normal expression of SREBP target genes, likely due to a compensatory increase in Srebf1a expression. Our results establish that SREBP-2 is critical for survival and limb patterning during development. Reduced expression of SREBP-2 from the hypomorphic allele leads to early death in females and reduced cholesterol content in the liver, but not in adipose tissue.

Indexed as

Gene Expression Regulation, DevelopmentalAdipose TissueAdiposityAllelesAnimalsCell LineEmbryonic DevelopmentExtremitiesFemaleHomeostasisLipid MetabolismLiverMaleMiceMutationSex CharacteristicsSterol Regulatory Element Binding Protein 1Sterol Regulatory Element Binding Protein 2cholesterol synthesisgene regulationsterol regulatory element-binding protein 1csterol regulatory element-binding protein 2

Identifiers

PMID26685326
PMCPMC4766990
OpenAlexW2280275814

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.